Guidelines from the CDC and the WHO recommend the wearing of face masks to prevent the spread of coronavirus (CoV) disease 2019 (COVID-19); however, the protective efficiency of such masks against airborne transmission of infectious severe acute respiratory syndrome CoV-2 (SARS-CoV-2) droplets/aerosols is unknown. Here, we developed an airborne transmission simulator of infectious SARS-CoV-2-containing droplets/aerosols produced by human respiration and coughs and assessed the transmissibility of the infectious droplets/aerosols and the ability of various types of face masks to block the transmission. We found that cotton masks, surgical masks, and N95 masks all have a protective effect with respect to the transmission of infective droplets/aerosols of SARS-CoV-2 and that the protective efficiency was higher when masks were worn by a virus spreader. Importantly, medical masks (surgical masks and even N95 masks) were not able to completely block the transmission of virus droplets/aerosols even when completely sealed. Our data will help medical workers understand the proper use and performance of masks and determine whether they need additional equipment to protect themselves from infected patients.
IMPORTANCE Airborne simulation experiments showed that cotton masks, surgical masks, and N95 masks provide some protection from the transmission of infective SARS-CoV-2 droplets/aerosols; however, medical masks (surgical masks and even N95 masks) could not completely block the transmission of virus droplets/aerosols even when sealed.
We developed an airborne transmission simulator of infectious droplets/aerosols produced by human respiration and coughs and assessed the transmissibility of the infectious droplets/aerosols produced and the ability of various types of face masks to block the transmission (Fig. 1, and see the Methods section in Text S1 in the supplemental material for additional details). A test chamber for airborne transmission experiments was constructed in a biosafety level 3 (BSL3) facility, and two mannequin heads were placed facing each other. One mannequin head was connected to a customized compressor nebulizer and exhaled a mist of virus suspension through its mouth, mimicking a virus spreader. The nebulizer was charged with 6 ml of virus suspension at the viral doses in culture medium indicated in Fig. 2 (without fetal calf serum) or diluted in phosphate-buffered saline to generate droplets/aerosols, and the respiration was exhaled continuously, simulating a mild cough at a flow speed of 2 m/s (2) for 20 min. Although the initial particle size exhaled was 5.5 ± 0.2 μm in mass median diameter (particle size percentages were as follows: <3 μm, 20%; 3 to 5 μm, 40%; >5 to 8 μm, 40% ), some of the droplets likely gradually evaporated and changed to aerosols. Therefore, both droplets and aerosols were likely present in the chamber. The other mannequin head was connected to an artificial ventilator through a virus particle collection unit. Tidal breathing, conducted by the artificial ventilator, was set to a lung ventilation rate representative of a steady state in adults. Face masks were attached to the mannequin heads, and the viral loads and infective virus that passed through the masks were measured by use of a plaque assay and quantitative real-time reverse transcription PCR (qRT-PCR), respectively.
Viral loads in the inhalation droplets/aerosols were inversely proportional to the distance between the virus spreader and the virus receiver; however, infectious virus was detected even 1 m away (Fig. 2A). The blue bars and the brown bars in the figures show the viral titers and viral RNA copy numbers, respectively. The numbers below each bar show the percentages relative to the leftmost control column values. When a mannequin exposed to the virus was equipped with various masks (cotton mask, surgical mask, or N95 mask), the uptake of the virus droplets/aerosols was reduced. A cotton mask led to an approximately 20% to 40% reduction in virus uptake compared to no mask (Fig. 2B). The N95 mask had the highest protective efficacy (approximately 80% to 90% reduction) of the various masks examined; however, infectious virus penetration was measurable even when the N95 mask was completely fitted to the face with adhesive tape (Fig. 2B). In contrast, when a mask was attached to the mannequin that released virus, cotton and surgical masks blocked more than 50% of the virus transmission, whereas the N95 mask showed considerable protective efficacy (Fig. 2C). There was a synergistic effect when both the virus receiver and virus spreader wore masks (cotton masks or surgical masks) to prevent the transmission of infective droplets/aerosols (Fig. 2D and E).
We next tested the protective efficacy of masks when the amount of exhaled virus was increased. The viral load was augmented to 108 PFU and exhaled by the spreader; then the uptake of the virus droplets/aerosols was measured when various types of masks were attached to the receiver. As with the lower viral load (5 × 105 PFU) shown in Fig. 2B, the N95 mask sealed with adhesive tape showed approximately 90% protective efficacy (see Fig. 2F and G for a comparison of two N95 products). When the amount of exhaled virus was reduced to 105 PFU or 104 PFU, infectious viruses were not detected, even in the samples from the unmasked receiver (Fig. 2H and I). Viral RNA was detected in all samples; however, due to the quantitative decrease, there was no difference in protective efficacy among all of the masks, including the sealed N95 masks.
Our airborne simulation experiments showed that cotton masks, surgical masks, and N95 masks had a protective effect with respect to the transmission of infective droplets/aerosols and that the protective efficiency was higher when masks were worn by the virus spreader. Considerable viral loads have been detected in the nasal and throat swabs of asymptomatic and minimally symptomatic patients, as well as those of symptomatic patients, which suggests transmission potential (4). Accordingly, it is desirable for individuals to wear masks in public spaces. Importantly, medical masks (surgical masks and even N95 masks) were not able to completely block the transmission of virus droplets/aerosols even when fully sealed under the conditions that we tested. In this study, infectious SARS-CoV-2 was exhaled as droplets/aerosols and mask efficacy was examined. To allow quantification, we conducted our studies by using a relatively high dose of virus, and under these conditions, it is possible that the protective capacity of the masks was exceeded. Although the efficiency of detecting infectious virus was reduced when the amount of exhaled virus was reduced, viral RNA was detected regardless of the type of mask used. These results indicate that it is difficult to completely block this virus even with a properly fitted N95 mask. However, it remains unknown whether the small amount of virus that was able to pass through the N95 masks would result in illness.
It has been reported that the stability of the virus in the air changes depending on the droplet/aerosol components, such as inorganics, proteins, and surfactants, suggesting that the permeation efficiency of masks is also affected by the components of viral droplets/aerosols (5, 6). In our experiments, the virus was suspended in culture supernatant without fetal calf serum or was diluted with phosphate-buffered saline. Further detailed analysis will be required to reveal the precise relationship between the protective efficiency of masks and the components of viral droplets/aerosols.
Our data will help medical workers understand the proper use and performance of masks (e.g., the importance of fitting masks and avoiding their reuse) and to determine whether they need additional protective equipment (e.g., a negative-pressure room or positive-pressure masks) to protect themselves from infected patients.
We thank S. Watson for editing the manuscript. We also thank M. Ito, M. Okuda, and J. Murakami (University of Tokyo) for technical assistance.
This research was supported by Japan Program for Infectious Diseases Research and Infrastructure from the Japan Agency for Medical Research and Development (AMED) (grant JP20wm0125002), by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from AMED (grant JP19fm0108006), and by the NIAID-funded Center for Research on Influenza Pathogenesis (CRIP; grant HHSN272201400008C).
The millions of Norway rats that live alongside New Yorkers are among the animals that can catch the virus that causes Covid-19, a new study says. However, reports of the virus spreading from any types of animals to humans remain rare. Pets like cats, dogs and...
Djokovic, who is unvaccinated against Covid-19, said last month that he had hoped for a "positive result" on being able to receive special permission to play tournaments in the US. Daniel Pockett/Getty Images/FILE CNN — Time might have run out for Novak Djokovic to...
NPR's Ari Shapiro speaks with Dr. Michael Osterholm about what the general public can understand about the origins of COVID-19. ARI SHAPIRO, HOST: Three years after the COVID-19 pandemic began, the debate over where it came from seems to be getting more confusing....
The Norwegian Gateway cruise ship is moored at PortMiami on Jan. 7 in Miami. The Centers for Disease Control and Prevention dropped its advisory warning Wednesday for cruise travel after more than two years of warning Americans. Joe Raedle/Getty Images The Center for...
A sign requiring the wearing of face masks is displayed at the testing center for visitors to the White House on July 30, 2022 in Washington, DC. Joshua Roberts/Getty Images There are still hundreds of thousands of COVID cases reported in the U.S. each week, along...
Taiwan Cloud Environmental Technology Co., Ltd
HeadOffice：2F, No. 128, 1st sec. Freedom Road, Taichung403, Taiwan.